Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 3
1972 1
1973 7
1974 1
1975 6
1976 3
1977 8
1978 1
1979 12
1980 10
1981 5
1982 9
1983 6
1984 4
1985 5
1986 5
1987 5
1988 10
1989 7
1990 10
1991 7
1992 8
1993 10
1994 12
1995 12
1996 8
1997 12
1998 14
1999 9
2000 10
2001 14
2002 8
2003 14
2004 6
2005 14
2006 9
2007 15
2008 9
2009 12
2010 8
2011 5
2012 10
2013 21
2014 5
2015 8
2016 5
2017 4
2018 8
2019 5
2020 11
2021 7
2022 5
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

412 results

Results by year

Filters applied: . Clear all
Page 1
Inhibition and induction of CYP enzymes in humans: an update.
Hakkola J, Hukkanen J, Turpeinen M, Pelkonen O. Hakkola J, et al. Among authors: pelkonen o. Arch Toxicol. 2020 Nov;94(11):3671-3722. doi: 10.1007/s00204-020-02936-7. Epub 2020 Oct 27. Arch Toxicol. 2020. PMID: 33111191 Free PMC article. Review.
Editorial.
Aschner M, Autrup HN, Cohen SM, Dekant W, Eisenbrand G, Galli CL, Gori GB, Kaminski NE, Klaassen CD, Klaunig JE, Levy L, Lotti M, Marquardt HW, Pelkonen O, Schrenk DF, Yamazaki H. Aschner M, et al. Among authors: pelkonen o. Regul Toxicol Pharmacol. 2019 Feb;101:A1-A2. doi: 10.1016/j.yrtph.2018.12.015. Regul Toxicol Pharmacol. 2019. PMID: 30642615 No abstract available.
Obfuscating transparency?
Aschner M, Autrup H, Berry CL, Boobis AR, Cohen SM, Dekant W, Galli CL, Goodman JI, Gori GB, Greim HA, Kaminski NE, Klaassen CD, Klaunig JE, Lotti M, Marquardt HW, Moretto A, Pelkonen O, Sipes IG, Wallace KB, Yamazaki H. Aschner M, et al. Among authors: pelkonen o. Regul Toxicol Pharmacol. 2018 Aug;97:A1-A3. doi: 10.1016/j.yrtph.2018.07.004. Epub 2018 Jul 11. Regul Toxicol Pharmacol. 2018. PMID: 30017904
Editorial.
Dietrich DR, von Aulock S, Marquardt H, Blaauboer B, Dekant W, Hengstler J, Collier A, Gori GB, Pelkonen O, Lang F, Nijkamp FP, Stemmer K, Li A, Savolainen K, Hayes AW, Gooderham N, Harvey A. Dietrich DR, et al. Among authors: pelkonen o. Regul Toxicol Pharmacol. 2013 Dec;67(3):317-20. doi: 10.1016/j.yrtph.2013.07.001. Epub 2013 Jul 9. Regul Toxicol Pharmacol. 2013. PMID: 23850959 No abstract available.
Cardiac safety of ophthalmic timolol.
Mäenpää J, Pelkonen O. Mäenpää J, et al. Among authors: pelkonen o. Expert Opin Drug Saf. 2016 Nov;15(11):1549-1561. doi: 10.1080/14740338.2016.1225718. Epub 2016 Aug 31. Expert Opin Drug Saf. 2016. PMID: 27534869 Review.
Hepatocytes: the powerhouse of biotransformation.
Sevior DK, Pelkonen O, Ahokas JT. Sevior DK, et al. Among authors: pelkonen o. Int J Biochem Cell Biol. 2012 Feb;44(2):257-61. doi: 10.1016/j.biocel.2011.11.011. Epub 2011 Nov 20. Int J Biochem Cell Biol. 2012. PMID: 22123318 Review.
Statement on the active substance flupyradifurone.
EFSA Panel on Plant Protection Products and their Residues (PPR); Hernandez Jerez A, Adriaanse P, Berny P, Coja T, Duquesne S, Focks A, Marinovich M, Millet M, Pelkonen O, Pieper S, Tiktak A, Topping C, Widenfalk A, Wilks M, Wolterink G, Rundlöf M, Ippolito A, Linguadoca A, Martino L, Panzarea M, Terron A, Aldrich A. EFSA Panel on Plant Protection Products and their Residues (PPR), et al. Among authors: pelkonen o. EFSA J. 2022 Jan 24;20(1):e07030. doi: 10.2903/j.efsa.2022.7030. eCollection 2022 Jan. EFSA J. 2022. PMID: 35106089 Free PMC article.
412 results